论文部分内容阅读
食管胃结合部腺癌(AEG)无论从发病机制还是生物学行为上,均不同于食管癌和胃癌,外科治疗时常需考虑是否行联合脏器切除术,尤其是脾脏切除。然而,行脾脏切除术对此类病人术后存活率的影响目前尚存在一定争议。因此,临床上行手术AEG治疗时,应首先明确肿瘤的不同分型、慎重考虑手术的难易程度、全面综合评估原发灶与脾脏的关系及脾门淋巴结的状态,再决定是否行联合脾脏等脏器切除术。
Esophagogastric junctional adenocarcinoma (AEG) is different from esophageal and gastric cancer both in pathogenesis and biological behavior, surgical treatment often need to consider whether combined with organ resection, especially splenectomy. However, the effect of splenectomy on the postoperative survival rate of these patients is still controversial. Therefore, the clinical operation of surgical AEG should first clear the different types of tumors, careful consideration of the degree of difficulty of surgery, a comprehensive and comprehensive assessment of the relationship between the primary tumor and spleen and lymph node status, and then decide whether the combination of the spleen Organ excision.